{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in a-synuclein (A30P and A53T) cause familial autosomal dominant PD, which shares many phenotypic similarities to sporadic PD, including deposition of a-synuclein in Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the A30P variant, linking it to familial autosomal dominant PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Microarrays provide a platform by which altered expression of large numbers of gene products can be measured in parallel without prior definition of the pathways involved.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (microarrays) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1, as it identifies altered gene expression relevant to PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Total RNA was isolated from clonal cell lines using Trizol, according to manufacturer's instructions, followed by an additional 'clean up' step using the Qiagen RNeasy kit.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of basic controls and replicates, indicating a robust experimental design.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Cells were grown in OptiMem media, supplemented with 10% (v/v) fetal bovine serum (FBS), penicillin streptomycin and 500 lg/mL G418.",
          "judgment": "No",
          "reasoning": "The paper does not mention the use of variant controls in the assay for the A30P variant.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P variant in SNCA was assessed for pathogenic functional evidence. The study used microarrays to identify altered gene expression relevant to PD, with basic controls and replicates, but lacked variant controls. The functional evidence strength is supporting (PS3_supporting)."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in a-synuclein (A30P and A53T) cause familial autosomal dominant PD, which shares many phenotypic similarities to sporadic PD, including deposition of a-synuclein in Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the A53T variant, linking it to familial autosomal dominant PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Microarrays provide a platform by which altered expression of large numbers of gene products can be measured in parallel without prior definition of the pathways involved.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (microarrays) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1, as it identifies altered gene expression relevant to PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Total RNA was isolated from clonal cell lines using Trizol, according to manufacturer's instructions, followed by an additional 'clean up' step using the Qiagen RNeasy kit.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of basic controls and replicates, indicating a robust experimental design.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Cells were grown in OptiMem media, supplemented with 10% (v/v) fetal bovine serum (FBS), penicillin streptomycin and 500 lg/mL G418.",
          "judgment": "No",
          "reasoning": "The paper does not mention the use of variant controls in the assay for the A53T variant.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T variant in SNCA was assessed for pathogenic functional evidence. The study used microarrays to identify altered gene expression relevant to PD, with basic controls and replicates, but lacked variant controls. The functional evidence strength is supporting (PS3_supporting)."
    }
  ]
}